Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis

Grant

Date/time Interval

  • December 9, 2019 - November 30, 2022
  • Total Award Amount

  • 192352.00
  • Direct Costs

  • 178104.00
  • Sponsor Award Id

  • K22CA237742
  • Contributor

  • Eric Ubil   Principal Investigator